Aspire Private Capital, LLC Astrazeneca PLC Transaction History

Aspire Private Capital, LLC

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 03, 2023	SELL	$64.85 - $71.7 $64 - $71	-1 Reduced 0.4%	251 $16,000
Q1 2023 May 30, 2023	SELL	$63.15 - $71.6 $252 - $286	-4 Reduced 1.56%	252 $17,000
Q1 2023 May 03, 2023	SELL	$63.15 - $71.6 $252 - $286	-4 Reduced 1.56%	252 $17,000
Q4 2022 May 30, 2023	BUY	$54.21 - $70.44 $216 - $281	4 Added 1.59%	256 $17,000
Q3 2022 Nov 10, 2022	SELL	$53.02 - $135.75 $106 - $271	-2 Reduced 0.78%	256 $14,000
Q4 2021 Feb 14, 2022	SELL	$54.02 - $63.83 $216 - $255	-4 Reduced 1.53%	258 $15,000
Q3 2021 Nov 15, 2021	BUY	$55.56 - $60.79 $3,000 - $3,282	54 Added 25.96%	262 $16,000
Q3 2020 Nov 13, 2020	BUY	$53.07 - $61.1 $11,038 - $12,708	208 New	208 $11,000
Q2 2020 Aug 13, 2020	SELL	$43.1 - $55.31 $344 - $442	-8 Closed	0 $0
Q1 2020 May 14, 2020	SELL	$37.79 - $51.33 $8,616 - $11,703	-228 Reduced 96.61%	8 $0
Q4 2019 Feb 11, 2020	BUY	$42.46 - $50.46 $382 - $454	9 Added 3.96%	236 $12,000
Q2 2019 Aug 13, 2019	BUY	$37.28 - $41.68 $708 - $791	19 Added 9.13%	227 $9,000
Q1 2019 May 13, 2019	SELL	$35.49 - $43.02 $261,880 - $317,444	-7,379 Reduced 97.26%	208 $8,000
Q4 2018 Feb 25, 2019	BUY	$36.86 - $41.49 $251,680 - $283,293	6,828 Added 899.6%	7,587 $288,000
Q4 2018 Feb 14, 2019	BUY	$36.86 - $41.49 $27,976 - $31,490	759 New	759 $288,000

1,339

478M

5.39M

3.75M

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $224B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

Get notified when there are updates to the investment portfolio of Aspire Private Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Aspire Private Capital, LLC with notifications on news.